4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18638678 | EVALUATING PRODUCTION BATCHES USING MACHINE-LEARNING | DANG, DUY M | 2662 | Non-Final OA | Apr 18, 2024 |
| 18447808 | LUNG CANCER COMBINATION THERAPY WITH IL-2 CONJUGATES AND AN ANTI-PD-1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF | PUTTLITZ, KARL J | 1646 | Non-Final OA | Aug 10, 2023 |
| 18201620 | USE OF ANTI-IL-27 ANTIBODIES | FAUST, AMBER KATHLEEN | 1643 | Non-Final OA | May 24, 2023 |
| 18043602 | Combination Therapy of a PD-1 Antagonist and an Antagonist for VEGFR-2 for Treating Patients with Cancer | KAUFMAN, CLAIRE M | 1674 | Non-Final OA | Mar 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial